Cooley Steers 2 Biotechs Planning Combined $252M In IPOs
A pair of life science companies represented by Cooley LLP said Monday that they expect to raise a combined $252 million in initial public offerings that will go toward further developing...To view the full article, register now.
Already a subscriber? Click here to view full article